Venetoclax Combined with Azacitidine vs Azacitidine in Acute Myeloid Leukemia - 102164

Spotlight
Video

Venetoclax Combined with Azacitidine vs Azacitidine in Acute Myeloid Leukemia

Loading........
Description: Jalaja Potluri, MD of AbbVie Inc. gives an overview of her abstract, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Venetoclax Combined with Azacitidine Versus Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia, which was presented at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract TPS7069: Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Venetoclax Combined with Azacitidine Versus Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia
Shared By : AnnualMeeting2017
Posted on : 06/15/17
Added : 7 months ago



Recommended

Nothing found.

More From AnnualMeeting2017

Nothing found.